These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22640183)

  • 1. Role of emmprin in endometrial cancer.
    Nakamura K; Kodama J; Hongo A; Hiramatsu Y
    BMC Cancer; 2012 May; 12():191. PubMed ID: 22640183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.
    Xue YJ; Lu Q; Sun ZX
    Med Oncol; 2011 Dec; 28(4):1363-72. PubMed ID: 20509007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
    Sato M; Nakai Y; Nakata W; Yoshida T; Hatano K; Kawashima A; Fujita K; Uemura M; Takayama H; Nonomura N
    PLoS One; 2013; 8(9):e74313. PubMed ID: 24073208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMMPRIN expression is associated with metastatic progression in osteosarcoma.
    Kim HS; Kim HJ; Lee MR; Han I
    BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.
    Zhang C; Tu Z; Du S; Wang Y; Wang Q
    Pathol Oncol Res; 2010 Mar; 16(1):47-53. PubMed ID: 19629755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased carbonyl reductase 1 expression promotes malignant behaviours by induction of epithelial mesenchymal transition and its clinical significance.
    Murakami A; Yakabe K; Yoshidomi K; Sueoka K; Nawata S; Yokoyama Y; Tsuchida S; Al-Mulla F; Sugino N
    Cancer Lett; 2012 Oct; 323(1):69-76. PubMed ID: 22542806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer.
    Nakamura K; Hongo A; Kodama J; Hiramatsu Y
    Int J Cancer; 2011 Jun; 128(11):2613-24. PubMed ID: 20715109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
    Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
    Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Wang T; Wang M; Fang S; Wang Q; Fang R; Chen J
    Oncotarget; 2017 Mar; 8(12):18991-19012. PubMed ID: 28177909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
    Xu Q; Ying M; Chen G; Lin A; Xie Y; Ohara N; Zhou D
    Tumour Biol; 2014 Aug; 35(8):7575-86. PubMed ID: 24793016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG; Nowak RA
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Alam K; Siddiquei MM; Mohammad G; Hertogh G; Mousa A; Opdenakker G
    Acta Ophthalmol; 2017 Nov; 95(7):697-704. PubMed ID: 27860331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in pancreatic neoplasm and pancreatic stellate cells.
    Zhang W; Erkan M; Abiatari I; Giese NA; Felix K; Kayed H; Büchler MW; Friess H; Kleeff J
    Cancer Biol Ther; 2007 Feb; 6(2):218-27. PubMed ID: 17224648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance of CD147 in genitourinary carcinomas.
    Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
    J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.
    Madigan MC; Kingsley EA; Cozzi PJ; Delprado WJ; Russell PJ; Li Y
    Cancer Immunol Immunother; 2008 Sep; 57(9):1367-79. PubMed ID: 18273614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.
    Yang J; Wang R; Li H; Lv Q; Meng W; Yang X
    Cancer Biomark; 2016 Jul; 17(2):237-47. PubMed ID: 27434292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of extracellular matrix metalloproteinase inducer in endometrial carcinoma with patient outcomes and clinicopathogenesis using monoclonal antibody 12C3.
    Ueda K; Yamada K; Urashima M; Ishibashi Y; Shirai M; Nikaido T; Takahashi H; Okamoto A; Saito M; Yasuda M; Ohkawa K; Tanaka T
    Oncol Rep; 2007 Apr; 17(4):731-5. PubMed ID: 17342307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD147 expression indicates unfavourable prognosis in prostate cancer.
    Han ZD; Bi XC; Qin WJ; He HC; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Chen ZN; Zhong WD
    Pathol Oncol Res; 2009 Sep; 15(3):369-74. PubMed ID: 19048397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of EMMPRIN expression in ovarian epithelial carcinomas.
    Zhao Y; Chen S; Gou WF; Niu ZF; Zhao S; Xiao LJ; Takano Y; Zheng HC
    Cell Cycle; 2013 Sep; 12(17):2899-913. PubMed ID: 23966157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.
    Yang JM; O'Neill P; Jin W; Foty R; Medina DJ; Xu Z; Lomas M; Arndt GM; Tang Y; Nakada M; Yan L; Hait WN
    J Biol Chem; 2006 Apr; 281(14):9719-27. PubMed ID: 16443928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.